Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06358950
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 92
Early research (Phase 1)Study completedNCT02259920
What this trial is testing

Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 13
Large-scale testing (Phase 3)Study completedNCT00605280
What this trial is testing

A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

Who this might be right for
Macular Edema Associated With Diabetes Mellitus
Pfizer 317
Testing effectiveness (Phase 2)Looking for participantsNCT06712680
What this trial is testing

A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes

Who this might be right for
Solid Tumor
Sichuan Huiyu Pharmaceutical Co., Ltd 115
Not applicableStudy completedNCT00699179
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,308
Not applicableUnknownNCT05921526
What this trial is testing

Effectiveness of Point-of-care Lung Ultrasound for the Management of Childhood Lower Respiratory Infections

Who this might be right for
Lower Respiratory InfectionLRTIPneumonia+1 more
Nagasaki University 616
Testing effectiveness (Phase 2)UnknownNCT03693326
What this trial is testing

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Who this might be right for
CancerLung Cancer MetastaticImmunotherapy
Asan Medical Center 70
Large-scale testing (Phase 3)UnknownNCT06545526
What this trial is testing

Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis

Who this might be right for
Familial Adenomatous Polyposis
Yonsei University 28
Post-approval studies (Phase 4)Study completedNCT00256126
What this trial is testing

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Who this might be right for
Growth Hormone DeficiencyTurner Syndrome
Merck KGaA, Darmstadt, Germany 318
Large-scale testing (Phase 3)Study completedNCT01257243
What this trial is testing

Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment

Who this might be right for
Cough
EMS 260
Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Early research (Phase 1)Study completedNCT02345408
What this trial is testing

Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Amgen 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT06106308
What this trial is testing

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

Who this might be right for
Metastatic Colorectal CancerCRCKRAS/NRAS Mutation
Cardiff Oncology 110
Large-scale testing (Phase 3)Active Not RecruitingNCT04975308
What this trial is testing

Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Eli Lilly and Company 874
Large-scale testing (Phase 3)Ended earlyNCT06107725
What this trial is testing

Maimonides Minocycline in Stroke Study

Who this might be right for
Stroke, AcuteIschemic StrokeHemorrhagic Stroke+2 more
Maimonides Medical Center 2
Large-scale testing (Phase 3)UnknownNCT04610476
What this trial is testing

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Who this might be right for
Psoriatic ArthritisWithdrawalReduction
University of Erlangen-Nürnberg Medical School 270
Testing effectiveness (Phase 2)Study completedNCT02249676
What this trial is testing

Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Devic's SyndromeDevic's Neuromyelitis OpticaDevic Syndrome+2 more
Tianjin Medical University General Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT06814717
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns

Who this might be right for
Thermal Burns
Neomatrix Therapeutics, Inc. 6
Testing effectiveness (Phase 2)UnknownNCT05519917
What this trial is testing

Study to Evaluate the Efficacy of Afatinib in Skull Base Chordoma

Who this might be right for
Chordoma of Clivus
Huashan Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05350917
What this trial is testing

Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard Therapy

Who this might be right for
HER2-positive or Mutated Advanced Colorectal Cancer
The First Affiliated Hospital of Zhengzhou University 20
Next Page